In the present study we therefore used an already established processing method that does not require MRI scans for co-registration (Joling et al., 2017; Vriend et al., 2014; Vriend et al., 2014), to be able to compare DAT and SERT binding in carefully matched PD and DLB patients and healthy controls. This evidence concerns the gene SLC6A3 and Parkinson disease.